We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$51.7M
2
MSFT icon
Microsoft
MSFT
+$40.6M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$20.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.9M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$31.8M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$27.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$21.9M
4
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$18.4M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$16.3M

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRGA
2851
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$9K ﹤0.01%
65
-1,318
-95% -$181K
SHSP
2852
DELISTED
SharpSpring, Inc.
SHSP
$9K ﹤0.01%
+999
New +$7.47K
AEGN
2853
DELISTED
Aegion Corp
AEGN
$9K ﹤0.01%
+341
New +$8.46K
TCP
2854
DELISTED
TC Pipelines LP
TCP
$9K ﹤0.01%
339
+242
+249% +$6.78K
HUD
2855
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$9K ﹤0.01%
+500
New +$8.35K
ZOM
2856
DELISTED
Zomedica Corp.
ZOM
$9K ﹤0.01%
+4,158
New +$8.35K
PACQU
2857
DELISTED
Pure Acquisition Corp. Unit
PACQU
$9K ﹤0.01%
+876
New +$8.93K
IOTS
2858
DELISTED
Adesto Technologies Corp
IOTS
$9K ﹤0.01%
1,070
+113
+12% +$989
SDRL
2859
DELISTED
Seadrill Limited Common Stock
SDRL
$9K ﹤0.01%
150
-443
-75% -$40.8K
WAAS
2860
DELISTED
AquaVenture Holdings Limited
WAAS
$9K ﹤0.01%
595
-5,124
-90% -$73.6K
EMCI
2861
DELISTED
EMC INS Group Inc
EMCI
$9K ﹤0.01%
+306
New +$8.11K
XRM
2862
DELISTED
Xerium Technologies Inc (new)
XRM
$9K ﹤0.01%
680
-94
-12% -$677
HYND
2863
DELISTED
WisdomTree Trust WisdomTree WisdomTree Negative Duration High Yield Bond Fund
HYND
$9K ﹤0.01%
+422
New +$9.02K
ACCO icon
2864
Acco Brands
ACCO
$407M
$8K ﹤0.01%
532
+412
+343% +$5.29K
ANIX icon
2865
Anixa Biosciences
ANIX
$116M
$8K ﹤0.01%
+2,666
New +$9.88K
ASND icon
2866
Ascendis Pharma A/S
ASND
$16.8B
$8K ﹤0.01%
115
+102
+785% +$6.71K
ATEX icon
2867
Anterix
ATEX
$1.94B
$8K ﹤0.01%
+318
New +$8.86K
BELFB
2868
Bel Fuse Inc Class B
BELFB
$4.21B
$8K ﹤0.01%
+362
New +$7.32K
CENT icon
2869
Central Garden & Pet Co
CENT
$2.8B
$8K ﹤0.01%
+230
New +$7.52K
CGEN icon
2870
Compugen
CGEN
$228M
$8K ﹤0.01%
2,375
-3,613
-60% -$13.6K
COTY icon
2871
Coty
COTY
$2.48B
$8K ﹤0.01%
557
-11,038
-95% -$170K
EDU icon
2872
New Oriental
EDU
$8.98B
$8K ﹤0.01%
88
-4,002
-98% -$383K
ENZL icon
2873
iShares MSCI New Zealand ETF
ENZL
$82.9M
$8K ﹤0.01%
173
– –
ET icon
2874
Energy Transfer Partners
ET
$69.3B
$8K ﹤0.01%
492
-68
-12% -$1.12K
FYT icon
2875
First Trust Small Cap Value AlphaDEX Fund
FYT
$193M
$8K ﹤0.01%
+199
New +$7.43K
113 114
115
116 117

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.